Blood, Vol. 93 No. 1 (January 1), 1999:
pp. 413-413
In the article by Mohri et al, entitled "Clinical Significance of
Inhibitors in Acquired von Willebrand Syndrome," which appeared in
the May 15, 1998 (Vol 91, No 10, pp 3623-3629) issue a correction should be noted. In the text on page 3624 under the Results section, in
the third paragraph the sentence that reads "was prolonged in 16 out
of 20 patients (80%)" should be changed to "was prolonged in 6 out of 8 patients evaluated (75%)." Also, in Table 2 on page 3625 some of the data was incorrectly written. The corrected Table is
reprinted below in its entirety.
